The Trump administration’s Centers for Medicare & Medicaid Services (CMS) has signaled that it will be revamping the process ...
(Reuters) - The U.S. government will consider opportunities to "bring greater transparency" for the Medicare drug price ...
The root of the U.S.’s high prescription drug prices lies in its unique system, which allows pharmaceutical manufacturers to ...
Through the issuance of Inauguration Day executive orders, the Trump Administration signaled its apparent intent to tackle ...
Democrats sought answers from RFK Jr. on how the Trump administration would handle Medicare price negotiations after a short ...
Minnesota Senator Amy Klobuchar is urging the Trump administration to continue negotiating lower prescription drug prices for ...
The second round of Medicare Part D price negotiations will feature two drugs familiar to rheumatologists — Ofev and Otezla — ...